Eventhough the advent of highly active antiretroviral therapy (HAART) has dramatically
improved patient outcome and provided a significant shrinking of the cases and severity of …

AIDS-defining neoplasms include Kaposi's sarcoma, primary central nervous system (CNS)
lymphoma, non-Hodgkin's lymphoma, and cervical carcinoma. These tumors are …

Malignant tumors currently rank among the leading cause of morbidity and mortality in
patients infected with HIV. The survival is increased for patients who benefits from better …

Malignancies represent a major cause of morbidity and mortality in human
immunodeficiency virus (HIV)-infected patients. The introduction of combined antiretroviral …

HIV infection is related to an increased risk of cancer compared with general population,
both AIDS-defining cancers (Kaposi's sarcoma, non Hodgkin's lymphoma, invasive cervical …

During the potent antiretroviral therapy era, the incidence of AIDS-defining cancers has
decreased and the incidence of non--AIDS-defining cancers (NADCs) has increased, as has …

The introduction of highly active antiretroviral therapy (HAART) has changed dramatically
the landscape of HIV disease. Deaths from AIDS-related diseases have been reduced by …

Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the pathogenesis and clinical presentation of Kaposi's sarcoma, with a special …

Immunodeficiency, whether congenital or acquired, iatrogenic (eg allograft recipients) or
infectious (eg human immunodeficiency virus (HIV)), is associated with an increased risk of …

Since the advent of HAART, patients with HIV infection have seen a significant improvement
in their morbidity, mortality, and life expectancy. The incidence of AIDS-defining illnesses …